In wild‐type MCF‐7 breast carcinoma cells and in MCF‐7 cells with (CRISPR/Cas9‐engineered) syntenin‐KO (SyntKO), compound C58 is not toxic at concentrations up to 100μM (Figure 3a). This evidence concerns the gene SDCBP and breast carcinoma.